Proprotein convertase subtilisin/kexin type 9 deficiency reduces melanoma metastasis in liver
about
The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functionsPCSK9 regulates apoptosis in human lung adenocarcinoma A549 cells via endoplasmic reticulum stress and mitochondrial signaling pathways.Regulation of HIF-1 alpha by the proprotein convertases furin and PC7 in human squamous carcinoma cellsLiving the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs.Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1)PCSK9 prosegment chimera as novel inhibitors of LDLR degradation.PCSK9 regulates apoptosis in human neuroglioma u251 cells via mitochondrial signaling pathways.Identification of PCSK9 as a novel serum biomarker for the prenatal diagnosis of neural tube defects using iTRAQ quantitative proteomics.Cancer subclonal genetic architecture as a key to personalized medicine.The dual behavior of PCSK9 in the regulation of apoptosis is crucial in Alzheimer's disease progression (Review).Proprotein convertase subtilisin kexin 9 inhibitors: next generation in lipid-lowering therapy.The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review.Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration.Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation.PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.Inhibitory effect of melanoma differentiation associated gene-7/interleukin-24 on invasion in vitro of human melanoma cancer cells.Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL/6 mice.The cross-talk of LDL-cholesterol with cell motility: insights from the Niemann Pick Type C1 mutation and altered integrin trafficking.Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cellsOvercoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationA transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer.The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol.Hypolipidemic effect of β-caryophyllene to treat hyperlipidemic rats.PCSK9 signaling pathways and their potential importance in clinical practice.Loss of disease tolerance during Citrobacter rodentium infection is associated with impaired epithelial differentiation and hyperactivation of T cell responses.In-vitro and In-vivo Hypolipidemic Activity of Spinach Roots and Flowers.Hepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9)
P2860
Q30541820-F6714A93-B914-44EB-B8AF-7BD626B6AEB2Q32176120-3A3E7A60-F6F0-48A7-B70B-1939DB3BDBDFQ33911578-505C01C0-A884-4835-8818-77FEC106225DQ34430377-184C8290-3A13-44C8-9057-4F68BB1153A8Q34723257-00CD095C-AB73-4148-8E68-A8BE917CF467Q34951227-7A983343-18C2-4497-B2C9-175AC14549F8Q35653477-BE6CEE9F-C109-4B3D-9F74-DC3AE1C8C182Q36392759-023F13F0-961A-4505-B552-6DA7176BE415Q37448116-7D86CAF0-2ADD-4474-916A-F3F7C79EE6D4Q37567746-FBF2A13F-718B-4362-90F3-5F71FA9E3307Q38285812-5650C020-34C4-461D-BE3A-BE27043D8466Q38637552-080FF334-9571-4DCB-A36D-934363244F70Q38818776-24698E76-A9D4-46AA-B025-D223180799A2Q38855416-B38CD0F3-251C-4973-B180-420189411E52Q38909525-B844E907-E102-41FB-9ADA-44A74FBA1228Q39138800-C43442D7-7070-453C-B16C-CB9A96C0F560Q41681515-0C4D5702-C705-46EA-9407-E65E680E0105Q41780762-3034A917-E22B-430A-9405-70165DA99E84Q41855396-50BBAC44-6FAB-41A2-A9EA-4D99629F9676Q41879186-7B618F89-3FED-4CE3-B998-64B236BFD981Q41949320-E1420487-4A38-4A7C-B220-21812E2ED387Q42367561-AF2D8FEE-E1E1-4E22-A25A-78FB427D1450Q46450941-E365621C-14C4-47A9-B024-BA1989F93121Q47134612-C187F0EA-C4D6-4A10-9A5D-F75F26823A64Q48231615-AF74561B-7DE2-470C-96E0-774FFA5D0060Q55474944-B6128534-F815-482A-9DCA-698183BC95DEQ58553684-CDAE1F77-6000-4E94-8CF6-95F931309948
P2860
Proprotein convertase subtilisin/kexin type 9 deficiency reduces melanoma metastasis in liver
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Proprotein convertase subtilis ...... s melanoma metastasis in liver
@ast
Proprotein convertase subtilis ...... s melanoma metastasis in liver
@en
type
label
Proprotein convertase subtilis ...... s melanoma metastasis in liver
@ast
Proprotein convertase subtilis ...... s melanoma metastasis in liver
@en
prefLabel
Proprotein convertase subtilis ...... s melanoma metastasis in liver
@ast
Proprotein convertase subtilis ...... s melanoma metastasis in liver
@en
P2093
P2860
P356
P1433
P1476
Proprotein convertase subtilis ...... s melanoma metastasis in liver
@en
P2093
Abdel M Khatib
Rachid Essalmani
Robert Day
Xiaowei Sun
P2860
P304
P356
10.1593/NEO.121252
P577
2012-12-01T00:00:00Z